GoodRx Holdings, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
GoodRx Holdings, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q2 2024.
  • GoodRx Holdings, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$8.23M, a 31.9% decline year-over-year.
  • GoodRx Holdings, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$29.9M, a 10.9% decline year-over-year.
  • GoodRx Holdings, Inc. annual Nonoperating Income (Expense) for 2023 was -$28.6M, a 14.4% decline from 2022.
  • GoodRx Holdings, Inc. annual Nonoperating Income (Expense) for 2022 was -$25M, a 5.88% decline from 2021.
  • GoodRx Holdings, Inc. annual Nonoperating Income (Expense) for 2021 was -$23.6M, a 15% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$29.9M -$8.23M -$1.99M -31.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$27.9M -$7.09M +$619K +8.03% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$28.6M -$6.35M +$135K +2.08% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$28.7M -$8.27M -$1.71M -26.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$27M -$6.24M -$128K -2.09% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$26.9M -$7.71M -$1.89M -32.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$25M -$6.48M -$596K -10.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$24.4M -$6.56M -$643K -10.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$23.7M -$6.11M -$219K -3.72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$23.5M -$5.82M +$72K +1.22% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$23.6M -$5.89M +$308K +4.97% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$23.9M -$5.92M +$326K +5.22% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$24.2M -$5.89M +$845K +12.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$25.1M -$5.89M +$2.67M +31.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$27.7M -$6.19M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$6.24M +$6.26M +50.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$6.74M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$8.56M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q3 2019 -$12.5M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.